Small Molecules

A snapshot of the global market forecast for the pharmaceutical excipients market.

What innovations are enabling a changeover to continuous?

Here, we speak with Matthew Moorcroft, Vice President of Marketing & Intelligence at Cambrex.

We need to produce molecules faster, more economically and with greater control.

The US opioid crisis has claimed the lives of hundreds of thousands. We examine pharma’s role.

Why are people still being prescribed giant tablets?

Denis Hunn from ystral takes us inside the world of the mixer, highlighting how technologies have changed over the years.

Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.

From patient-centric design to speciality excipients and security of supply; what are the latest trends in formulation strategies?